← Back to Patent Explorer
US3959476A Expired / Lapsed US ⏱️ 0.0 years remaining

Antihypertensive substituted triazoles

Assignee: Astra Lakemedel AB
•
Filing: 1974-06-11
•
Granted: 1976-05-25
•
Expires: 1994-06-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds having the general formula METHODS FOR THE PREPARATION THEREOF AND USE IN THE TREATMENT OF HYPERTENSION.

Inventors

  • 👤 Hans Erik Eriksson
  • 👤 Gosta Lennart Florvall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 04:58
CPC Classifications
C; C07; C07D; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/14

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 86 words
A compound of the formula ##SPC9## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen.
Claim 2
Dependent Claim 86 words
A compound of the formula ##SPC9## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen.
Claim 3
Dependent Claim 75 words
A compound according to claim 1 characterized by the formula I, or a pharmaceutically acceptable salt thereof, in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom and R 5 represents a hydrogen atom, provided that R 1 , R 2 and R 3 are not all simultaneously hydrogen.
Claim 4
Dependent Claim 17 words
A compound according to claim 1 characterized by the formula ##SPC10## or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 112 words
An antihypertensive pharmaceutical preparation which comprises as active ingredient from 0.1% to 95% by weight of said preparation of a compound of the formula ##SPC11## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen, in association with a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim 112 words
An antihypertensive pharmaceutical preparation which comprises as active ingredient from 0.1% to 95% by weight of said preparation of a compound of the formula ##SPC11## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen, in association with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 64 words
An antihypertensive pharmaceutical preparation according to claim 4 wherein R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom and R 5 represents a hydrogen atom, provided that R 1 , R 2 and R 3 are not all simultaneously hydrogen.
Claim 8
Independent Claim 117 words
A method for the treatment of hypertension, which comprises administration to a host suffering from such ailment an antihypertensive pharmaceutical preparation which comprises, as active ingredient, a therapeutically acceptable amount of a compound of the formula ##SPC12## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen.
Claim 9
Independent Claim 117 words
A method for the treatment of hypertension, which comprises administration to a host suffering from such ailment an antihypertensive pharmaceutical preparation which comprises, as active ingredient, a therapeutically acceptable amount of a compound of the formula ##SPC12## or a pharmaceutically acceptable salt thereof in which formula R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom or a lower alkyl group and R 5 represents a hydrogen atom or a lower alkyl group, provided that R 4 is a lower alkyl group when R 1 , R 2 and R 3 are all hydrogen.
Claim 10
Dependent Claim 62 words
A method according to claim 6, wherein R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R 4 represents a hydrogen atom and R 5 represents a hydrogen atom, provided that R 1 , R 2 and R 3 are not all simultaneously hydrogen.

References Cited (Backward Citations)

US3516995A Cited
US3775405A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-05-25 1979-11-24 1980-05-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-05-25 1983-11-24 1984-05-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-05-25 1987-11-24 1988-05-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag